PHILADELPHIA, PA — CLEU Diagnostics has announced the expansion of its commercial advisory board with the addition of two seasoned leaders in the diagnostics field, Jill Thompson and Harold Kisner, PhD, MBA. This move underscores the company’s commitment to advancing its LabSimple platform, a groundbreaking point-of-care diagnostic technology.
Thompson, principal at JoLT Group and a veteran in life sciences and diagnostics, brings a wealth of experience in guiding startups, turnarounds, product development, and commercialization. Her network of industry insiders has been instrumental in securing numerous licensing agreements, joint ventures, and acquisitions. “LabSimple checks all the boxes and is really a culmination of what we as an industry have been hoping to achieve for a long time,” Thompson remarked about the platform’s potential.
Joining her is Dr. Kisner, a recognized authority in laboratory diagnostics with decades of leadership in clinical lab operations and automation. His career includes key roles as Chief Operating Officer and Laboratory Director at Path Lab Inc., as well as Chief Laboratory Officer at DaVita Laboratories. Dr. Kisner emphasized the disruptive potential of the LabSimple platform, stating, “Its remarkable capability makes it possible to introduce extremely advanced laboratory techniques into any market that would usually only be possible with large, expensive purpose-built instruments. This is an exciting advancement for our industry.”
With Thompson and Kisner on board, CLEU Diagnostics positions itself for continued innovation and commercialization success. Their combined expertise adds significant momentum to the company’s vision of revolutionizing the diagnostics landscape with cutting-edge, accessible solutions like LabSimple.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.